Loading...
Advicenne S.A.
ALDVI.PA•EURONEXT
Healthcare
Biotechnology
€1.76
€0.01(0.57%)
Advicenne S.A. (ALDVI.PA) Company Profile & Overview
Explore Advicenne S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Advicenne S.A. (ALDVI.PA) Company Profile & Overview
Advicenne S.A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria. Advicenne S.A. was founded in 2007 and is headquartered in Paris, France.
SectorHealthcare
IndustryBiotechnology
CEOMr. Didier Laurens
Contact Information
Company Facts
21 Employees
IPO DateDec 6, 2017
CountryFR
Actively Trading